BioHealth News
Navigating the AI Wave: Dr. Juergen Klenk Explores AI’s Reality in the BioHealth Industry on BioTalk
Have you ever wondered about the true impact of Artificial Intelligence (AI) in the BioHealth industry? In this episode of BioTalk with Rich Bendis,…
Read More
citybiz: Irazu Oncology Secures $2.6M Debt to Advance UMB’s Vaccine Technology
Irazu Oncology, which is using a platform built by researchers at University of Maryland, Baltimore to develop cancer vaccines, has secured $2.6 million in debt from an undisclosed source,…
Read More
WBJ: United Therapeutics eyes big organ production facility in Silver Spring
By Dan Brendel – Staff Reporter, Washington Business Journal Dec 15, 2023 - United Therapeutics Corp. is teeing up major organ production facility at its Silver Spring…
Read More
How Polaris Genomics, a JLABS @ Washington, DC resident, is leveraging the Health Equity Assessment Tool to enable a more equitable innovation process
December 11, 2023 - What if there was a diagnostic test that could confirm or predict post-traumatic stress disorder? And what if people from…
Read More
Fierce Healthcare: Previous Crab Trap Winner Floreo nabs FDA breakthrough label for its VR software
By Anastassia Gliadkovskaya - Dec 11, 2023 4:00pm - Floreo, maker of virtual reality (VR) behavioral therapy content, has received the Food and Drug Administration’s…
Read More
NeoImmuneTech and Imugene enter into strategic research collaboration to improve cancer treatments
The collaboration will evaluate the ability of NeoImmuneTech's immune cell amplifier NT-I7 to increase the number of azer-cel allogeneic CAR T cells per batch…
Read More
University of Maryland, Baltimore Startup GlycoMantra Awarded $3.7 Million Small Business Innovation Research Phase II Grant
BALTIMORE, Maryland, December 11, 2023 – GlycoMantra, a University of Maryland, Baltimore (UMB) startup company developing therapeutics for unmet medical needs in metastatic castration-resistant prostate…
Read More
BioTalk Podcast – Pioneering Solutions: Dr. Nehal Mehta’s Quest to Combat Chronic Diseases at Mobius Scientific
Are you ready to dive into the world of groundbreaking biotechnology and the fight against chronic diseases? In this episode of BioTalk with Rich…
Read More
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene…
Read More
CBS19 – UVA to break ground on new biotechnology institute
ALBEMARLE COUNTY, Va. (CBS19 NEWS) -- State and local officials will be on hand for a groundbreaking ceremony at the University of Virginia on Friday.…
Read More
University of Maryland and BioGenCell Announce the Launch of BioGenCell Fifth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
BALTIMORE, Dec. 7, 2023 /PRNewswire/ -- BioGenCell, a pioneer in personalized cell therapy solutions, is excited to announce the launch of its fifth Phase II clinical…
Read More
Washington’s Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has acquired U.S. and Canadian rights to PONVORY® (ponesimod) from Actelion Pharmaceuticals…
Read More
ARPA-H Selects Site for Stakeholder & Operations Hub
ARPA-H made its final hub location decision, selecting the historic Bowen Building in downtown Washington, D.C. as the site for its Stakeholder & Operations…
Read More
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today announced that the company has been named on Newsweek’s list…
Read More
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study
ROCKVILLE, M.D. and SUZHOU, China, Dec. 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines…
Read More